fda glp-1 compounding enforcement news october 2025 Crackdown GLP-1 online advertising overstates benefits

Digestive Comfort Support Botanical blend traditionally used to promote regularity and digestive wellness

Leading Players in the GLP-1 Market Novo Nordisk 38.72% Ozempic Wegovy Rybelsus Eli Lilly 28.41% Mounjaro Zepbound Sanofi 8.76% 4 AstraZeneca 6.62% 5 GSK 4.95% 6 Regeneron 3.27% 7 Pfizer 2.61% 8 Amgen 1.98% 9 Sun Pharma 1.52% Boehringer Ingelheim 1.24% Together, Novo Nordisk and Eli Lilly account for more than 67% of the market, highlighting the intense competition between the two companies that currently lead the obesity and diabetes treatment revolution

The glucagon-like peptide-1 receptor agonist (GLP-1) liraglutide may protect the brains of people with mild Alzheimers disease (AD) and reduce cognit

Echelon has been a fitness industry player since 2017and now its leveling up with ActiveMD, offering customers access to weight loss drugs.

Jan 12 (Reuters) - Oral weight-loss drugs could make up a third or more of the overall GLP-1 market by 2030, a larger percentage than the company originally anticipated, a Novo Nordisk executive said